Neurokinin receptor antagonists

被引:38
作者
Seward, EM [1 ]
Swain, CJ [1 ]
机构
[1] Merck Sharp & Dohme Ltd, Neurosci Res Ctr, Res Labs, Harlow CM20 2QR, Essex, England
关键词
depression; emesis; migraine; neurokinin; neurokinin receptor antagonist; substance P;
D O I
10.1517/13543776.9.5.571
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The area of neurokinin research is now beginning to come of age following the publication of a number of clinical trials. Positive clinical results have been reported from a variety of anti-emetic trials of neurokinin-1 (NK1) receptor antagonists. These agents offer a clinical advantage over existing therapies in that delayed emesis resulting from cancer chemotherapy has now been addressed as well as post-operative emesis. The first successful clinical evidence supporting the use of a selective NK2 receptor antagonist in asthma has been revealed. A selective NK1 receptor antagonist was found to have excellent antidepressant and anxiolytic activity in a recent Phase II depression trial; this represents the first new mechanistic approach to depression in forty years. To date there has been no clinical evidence to support the use of NK1 antagonists in pain. Patent claims covering a diverse array of structural classes and new indications continue to flourish in an arena dominated by most of the leading pharmaceutical companies.
引用
收藏
页码:571 / 582
页数:12
相关论文
共 105 条
  • [31] THE NONPEPTIDE NEUROKININ(1)-RECEPTOR ANTAGONIST, RP-67580, BLOCKS NEUROGENIC PLASMA EXTRAVASATION IN THE DURA-MATER OF RATS
    SHEPHEARD, SL
    WILLIAMSON, DJ
    HILL, RG
    HARGREAVES, RJ
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1993, 108 (01) : 11 - 12
  • [32] COMPARISON OF THE EFFECTS OF SUMATRIPTAN AND THE NK1 ANTAGONIST CP-99,994 ON PLASMA EXTRAVASATION IN DURA-MATER AND C-FOS MESSENGER-RNA EXPRESSION IN TRIGEMINAL NUCLEUS CAUDALIS OF RATS
    SHEPHEARD, SL
    WILLIAMSON, DJ
    WILLIAMS, J
    HILL, RG
    HARGREAVES, RJ
    [J]. NEUROPHARMACOLOGY, 1995, 34 (03) : 255 - 261
  • [33] SUAREZ GA, 1994, NEUROLOGY, V44, pP373
  • [34] The effect of the NK2 tachykinin receptor antagonist SR 48968 (saredutant) on neurokinin A-induced bronchoconstriction in asthmatics
    Van Schoor, J
    Joos, GF
    Chasson, BL
    Brouard, RJ
    Pauwels, RA
    [J]. EUROPEAN RESPIRATORY JOURNAL, 1998, 12 (01) : 17 - 23
  • [35] 1997, Patent No. 01554
  • [36] 1997, Patent No. 38692
  • [37] 1997, Patent No. 03066
  • [38] 1998, Patent No. 24444
  • [39] 1997, Patent No. 45119
  • [40] 1997, Patent No. 5594022